European Event-Driven Analyst

Jesus Rodriguez Aguilar

Event-Driven

<ul>
<li>The Offer has been accepted for 19.2% of the current share capital, which means that EQT will control 98.2% of the shares.</li>
<li>Those who tendered will receive a €3.2/share interim dividend (€2.72/share net) on 4 October, and €12.8/share on 6 October. EQT doesn't intend to seek a squeeze-out.</li>
<li>Investors in SUSE who have not tendered will become soonish shareholders in an unlisted company. Buying now means an 18.8% yield (net), and hoping for a future purchase offer.</li>
</ul>


The Offer has been accepted for 19.2% of the current share capital, which means that EQT will control 98.2% of the shares.
Those who tendered will receive a €3.2/share interim dividend (€2.72/share net) on 4 October, and €12.8/share on 6 October. EQT doesn't intend to seek a squeeze-out.
Investors in SUSE who have not tendered will become soonish shareholders in an unlisted company. Buying now means an 18.8% yield (net), and hoping for a future purchase offer.


<ul>
<li>EQT offers €16/share to delist <a href="https://www.smartkarma.com/entities/suse-sa" target="_blank" data-smartkarma-citation="entities:40044:1" rel="noopener">SUSE (SUSE GR)</a> (split into consideration and interim dividend) and merge it into a Luxembourg SA. On 24 August, EQT published the offer document.</li>
<li>There will be no squeeze-out. The multiples offered (4.8x EV/NTM Fwd Revenue, 14x EV/Fwd NTM EBITDA, source: IBES) are generally consistent with European software companies.</li>
<li>With the stock trading at a 3% gross spread, I see limited upside from here and no interloper risk. Annualised spread is 33.4%. Long and tender.</li>
</ul>


EQT offers €16/share to delist SUSE (SUSE GR) (split into consideration and interim dividend) and merge it into a Luxembourg SA. On 24 August, EQT published the offer document.
There will be no squeeze-out. The multiples offered (4.8x EV/NTM Fwd Revenue, 14x EV/Fwd NTM EBITDA, source: IBES) are generally consistent with European software companies.
With the stock trading at a 3% gross spread, I see limited upside from here and no interloper risk. Annualised spread is 33.4%. Long and tender.


Pan-Asia Index Flows & Special Situations, Quiddity Advisors

Janaghan Jeyakumar, CFA

Pan-Asia Index Flows & Special Situations

Quiddity Advisors

Pan-Asia Catalysts/Events

<ul>
<li>In this insight, we take a look at the names leading the race to become ADDs/DELETEs for the DAX, MDAX, and SDAX Indices in the December 2023 Rebalance.</li>
<li>Currently, I see two index changes for the MDAX index and two index changes for the SDAX index.</li>
<li>I do not see any changes for the DAX index in December 2023.</li>
</ul>


In this insight, we take a look at the names leading the race to become ADDs/DELETEs for the DAX, MDAX, and SDAX Indices in the December 2023 Rebalance.
Currently, I see two index changes for the MDAX index and two index changes for the SDAX index.
I do not see any changes for the DAX index in December 2023.


Quiddity Leaderboard-DAX Dec 23: Two Changes for MDAX and Two Changes for SDAX

<ul>
<li>In this insight, we take a look at the names leading the race to become ADDs/DELETEs for the DAX, MDAX, and SDAX Indices in the September 2023 Rebalance.</li>
<li>I currently do not see any index changes for DAX but <a href="https://www.smartkarma.com/entities/fresenius-medical-care-ag-co" target="_blank" data-smartkarma-citation="entities:21622:1" rel="noopener">Fresenius Medical Care &amp; (FME GR)</a> and <a href="https://www.smartkarma.com/entities/zalando-se" target="_blank" data-smartkarma-citation="entities:21746:1" rel="noopener">Zalando (ZAL GR)</a> are close to being an ADD and DELETE respectively.</li>
<li>I see one change for the MDAX index. Separately, there could be up to three SDAX change in the run up to the December 2023 review including one intra-review change.</li>
</ul>


In this insight, we take a look at the names leading the race to become ADDs/DELETEs for the DAX, MDAX, and SDAX Indices in the September 2023 Rebalance.
I currently do not see any index changes for DAX but Fresenius Medical Care &amp; (FME GR) and Zalando (ZAL GR) are close to being an ADD and DELETE respectively.
I see one change for the MDAX index. Separately, there could be up to three SDAX change in the run up to the December 2023 review including one intra-review change.


Quiddity Leaderboard-DAX Dec 23: One MDAX Change and Three SDAX Changes Possible

Germany

SUSE S.A. provides enterprise software solutions. The Company offers hybrid cloud IT and cloud-native transformation solutions. SUSE serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

SUSE (SUSE GR)

Offer Results and Interim Dividend

The Offer has been successful, so EQT will control 98.2% of the shares. Investors who have not tendered will become soonish shareholders in an...

Jesus Rodriguez Aguilar

EQT/SUSE: Terms and Spread

The multiples offered are generally consistent with European software companies. With the stock trading at a 2.9% gross spread, I see limited...

Jesus Rodriguez Aguilar

Quiddity Leaderboard-DAX Dec 23: Two Changes for MDAX and Two Changes for SDAX

The expected MDAX changes could have multiple days to trade while the flow expectations for the expected SDAX changes are fairly insignificant.

Janaghan Jeyakumar, CFA

Quiddity Leaderboard-DAX Dec 23: One MDAX Change and Three SDAX Changes Possible

The highest-ranked non-DAX member Fresenius Medical Care (FME GR) is currently ranked 34th and if the stock achieves a 6% relative gain vs the...

Janaghan Jeyakumar, CFA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)